May 29, 2024

FDA Accelerates Review of Keytruda Combo as Initial Therapy for Inoperable Advanced or Metastatic Malignant Pleural Mesothelioma.

Frank Dolan May 29, 2024

AI Boosts Biopharma Sustainability, but at What Environmental Cost?

Arsenal May 29, 2024

AI for Greener Biopharma: Balancing Sustainability and Environmental Cost

Arsenal May 29, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

WuXi AppTec Faces US Revenue Decline for First Time in Five Years: Impacts of the Biosecure Act

WuXi AppTec Faces US Revenue Decline for First Time in Five Years: Impacts of the Biosecure Act

UK Government's Controversial Move: Doubling Pharmaceutical Rebates Could Impact NHS Funding and Drug Prices

UK Government’s Controversial Move: Doubling Pharmaceutical Rebates Could Impact NHS Funding and Drug Prices

First Timers Club: Biopharma Launches in 2025 and 2026

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA